New research highlights potential of cytisine for global smoking cessation efforts
January 04, 2024 by news-medical.net
New research highlights potential of cytisine for global smoking cessation efforts
A new study published in Addiction has found that cytisine, a low-cost, generic stop-smoking aid that has been used in eastern Europe since the 1960s, increases the chances of successful smoking cessation by more than two-fold compared with placebo and may be more effective than nicotine replacement therapy. It has a benign safety profile, with no evidence of serious safety concerns. Sounds perfect for your New Year resolution, doesn't it? But there's a catch: Cytisine is not licensed or marketed in most countries outside of central and eastern Europe, making it unavailable in most of the world, including many low- and middle-income countries where it could make a big difference to global health.
TOP NEWS by REGION
RELATED VIDEOS
RELATED VIDEOS
14 April 2024
Should we be reconsidering our perceptions of nicotine?
17 February 2025
How does misinformation about vaping in Mexico shape public perception?
29 June 2017
Nicotine replacement meets smoking displacement.
17 March 2025
Talking About Tobacco Harm Reduction
29 June 2018
Rethinking nicotine across the lifespan: what about the older smoker?
29 June 2017
Toxicant exposure: a comparison between e cigarettes and heat not burn
24 June 2024
Are we losing the war against cigarettes? #GFN24
24 June 2023
[EN] Global Forum on Nicotine 2023 Day #4